ASN to Help Improve Adult Immunization Rates for High-Risk Adults

Under a five-year cooperative agreement awarded by the Centers for Disease Control and Prevention to the Council of Medical Specialty Societies, ASN, along with six other member subspeciality societies, will help improve adult immunization rates for high-risk adults.

Under a five-year cooperative agreement awarded by the Centers for Disease Control and Prevention to the Council of Medical Specialty Societies (CMSS), ASN, along with six other member subspeciality societies, will help improve adult immunization rates for high-risk adults. The agreement, which includes $22 million in funding in the first year (with an estimated $55.5 million over five years), will support increased COVID-19, influenza, and routine vaccinations in high-risk adults with chronic medical conditions, including patients with chronic obstructive pulmonary disease, asthma, diabetes, heart disease, cancer, and chronic kidney disease, as well as older adults and staff in occupational health settings. 

CMSS will partner with seven member subspeciality societies who care for these patient populations; in addition to ASN, these societies include the American Association of Clinical Endocrinology, American College of Cardiology, American College of Occupational and Environmental Medicine, American Geriatrics Society, American Society of Clinical Oncology, American Society of Nephrology, and the American Thoracic Society. 

“These seven collaborating specialty societies have remarkable reach and extensive expertise in national quality improvement initiatives, including targeted continuing education and outreach to drive vaccination for at-risk adult populations,” observed CMSS in press release. “Each has long-standing relationships with health systems and clinics that will be the backbone of this improvement initiative.”

The project aims to ensure that all adults, especially high-risk adults with co-morbidities, receive up-to-date vaccinations for influenza, COVID-19, and all applicable vaccines. CMSS will serve as the lead organization and as a catalyst to work with 45 member societies, seven collaborating subspecialty members, and partnering healthcare systems to incorporate the Standards for Immunization Practice into clinical care and drive adult immunization through education, dissemination, and quality improvement initiatives.

The work will involve implementing targeted immunization and quality improvement strategies and activities to support increased vaccination of high-risk patients, as well as partnering with healthcare systems to develop, promote, and implement quality improvement platforms to improve adult vaccination. It will also include developing and updating vaccine policy statements to advance standards; promoting continuing education, resources, and strategies; training vaccine immunization champions to encourage outreach and education with subspeciality providers; and convening national and regional meetings to share best practices and lessons learned.
 

Save